Our Mission
The mission of DSRTF is to stimulate biomedical research that will accelerate the development of treatments to significantly improve cognition for individuals with Down syndrome.
Learn More.
Now Is the Time To Energize DS Research
The recent mapping of the human genome has ushered in an unprecedented opportunity for Down syndrome research. For the first time in our history scientists now have tools, techniques, and mouse models of DS that are making it easier to understand the biology of Down syndrome. The goal is clear – the identification of treatments aimed at improving learning, memory, speech
and even the late in life neurological decline experienced by those with Down
syndrome.
A Small Change in Cognitive Capability Could Have Profound Impact on Independence
Because the majority of individuals with Down syndrome fall into the mild to moderate range of cognitive impairment, a 10-20% improvement in cognitive capability can provide a greater number of people with the ability to live independently, to hold a job and to be more integrated into their communities.
 |
|
DSRTF Grant Award Recipients Discover a New Potential Therapeutic Strategy to Improve Cognition in Down Syndrome
The Down Syndrome Research and Treatment Foundation (DSRTF) is pleased to announce the publication of an article in Science Translational Medicine on November 18 by DSRTF-supported researchers, Drs. Ahmad Salehi, William Mobley, and colleagues, which describes a new potential therapeutic strategy to address cognitive decline and improve cognition in Down syndrome. Learn More»
DSRTF Awards $1.4 Million for New Research Grants to Advance Cognition Research and Potential New Therapies in Down Syndrome
The Down Syndrome Research and Treatment Foundation (DSRTF) announces the award of $1.4 million in funding for five new DSRTF Research Grants. Researchers at Johns Hopkins University School of Medicine, University of California, San Diego School of Medicine, Stanford University School of Medicine and the University of Arizona are the recipients of this latest round of DSRTF grant funding. This represents the highest annual grant funding level since DSRTF’s founding in 2004.
The focus of the new DSRTF Research Grants for 2009-2010 is to significantly build upon the DSRTF-supported research that has led to dramatic breakthroughs in defining specific mechanisms responsible for cognitive impairment in Down syndrome, as well as the identification and pursuit of five new potential drug targets for improving cognitive function. The new grants will also focus on overcoming potential critical challenges for new clinical trials. Learn More»
DSRTF Receives Prestigious 2009 Christian Pueschel Memorial Research Award
On August 1, 2009, The Down Syndrome Research and Treatment Foundation (DSRTF) was awarded the prestigious 2009 Christian Pueschel Memorial Research Award from the National Down Syndrome Congress (NDSC). The award was presented to DSRTF’s CEO, Dr. Michael Harpold, by Dr. Sigfried Pueschel at an awards banquet during the NDSC Annual Convention in Sacramento, CA. Learn More»
|
Interested in organizing a DSRTF event in your area in 2010? Contact us and we'll help you get started!
You can now follow DSRTF on Facebook and Twitter
 
CLICK HERE TO SEE PHOTOS FROM PAST DSRTF EVENTS »
CLICK HERE TO SEE DSRTF'S VOLUNTEER SPOTLIGHT »
|
